News Focus
News Focus
Followers 1
Posts 215
Boards Moderated 0
Alias Born 02/28/2006

Re: DewDiligence post# 15896

Friday, 09/02/2016 9:24:55 AM

Friday, September 02, 2016 9:24:55 AM

Post# of 20689
Even if MYL no longer felt it had a viable Copax, they may have decided that it was in their interest to continue to pursue these patents just for the PR value to offset the negative press on EPI.

It would make for an uncomfortable relationship if MNTA had to sue MYL if the latter actually get their Copaxone approved.